305. Prevalence of Ceftriaxone Susceptible, Piperacillin-tazobactam Non-susceptible Escherichia coli Bacteremia in Patients with Hematologic Malignancy

BACKGROUND: Piperacillin-tazobactam (TZP) is common empiric and targeted therapy for gram-negative bacteremia in patients with hematologic malignancy. Resistance to TZP tends to occur concurrently with ceftriaxone (CRO) resistance; however, the prevalence of TZP nonsusceptibility in CRO susceptible...

Descripción completa

Detalles Bibliográficos
Autores principales: Spitznogle, Sarah L, Rausch, Caitlin R, Bhatti, Micah M, Shelburne, Samuel A, Aitken, Samuel L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776808/
http://dx.doi.org/10.1093/ofid/ofaa439.348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776808/
http://dx.doi.org/10.1093/ofid/ofaa439.348

Ejemplares similares